Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Gross Profit (QoQ) (2010 - 2026)

Analysis

Repligen (RGEN) Gross Profit (QoQ) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62%
Mar 31, 2026 4.29%
Dec 31, 2025 3.30%
Sep 30, 2025 8.09%
Jun 30, 2025 1.78%
Mar 31, 2025 135.24%
Dec 31, 2024 -49.87%
Sep 30, 2024 -4.95%
Jun 30, 2024 6.16%
Mar 31, 2024 -2.16%
Dec 31, 2023 114.69%
Sep 30, 2023 -54.22%
Jun 30, 2023 -4.40%
Mar 31, 2023 -13.04%
Dec 31, 2022 -15.90%
Sep 30, 2022 -5.89%
Jun 30, 2022 -2.15%
Mar 31, 2022 18.73%
Dec 31, 2021 1.71%
Sep 30, 2021 1.73%